Bristol-Myers Squibb extends deal with DKSH in SE Asia

Bristol-Myers Squibb has extended its partnership with DKSH to provide commercialization and distribution services across Southeast Asia.

Today the market expansion company announced it has extended a deal first penned in 2010 with BMS, focused on assisting the Big Pharma in growing its presence in Hong Kong, Malaysia, Singapore,Taiwan, Thailand and Vietnam.

This updated contract will see DKSH provide marketing, sales, warehousing, physical distribution, credit management and collection services for BMS across those six countries.

In the last few years, DKSH has won and extended a number of contracts with pharma companies looking to expand their presence in Southeast Asia. Nordic Biosciences was the latest to ink a deal for clinical trial logistics services in Hong Kong last December, joining Bayer, Pfizer, and GSK, amongst others, in partnering with DKSH last year.

It is not only multinationals looking to expand their presence in the region but local firms too. In February, DKSH expanded by buying Macau-based distributor Glory and spokesman Michael Hofer told this publication this was due to “an increased demand for market expansion services from Asian pharma companies who are expanding their business in the region.”